Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts
J Nucl Med (in press)
DOI 10.2967/jnumed.125.270444, PubMed 41043994
CNN-based prediction using early post-radiotherapy MRI as a proxy for toxicity in the murine head and neck
Acta Oncol, 64, 1312-1320
DOI 10.2340/1651-226X.2025.44020, PubMed 40995989
Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab
Biomed Pharmacother, 191, 118550
DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
More publications